Q4 FY26 quarterly results (January-March 2026)

5,116 companies have declared Q4 FY26 results so far, the latest on 15 Oct 2026.

Across the 4,645 non-financial companies with a year-ago quarter to compare, sales grew +12.4% and net profit +34.1% year on year, and the combined operating margin widened 10 bps to 14.3%.

For the 120 banks and lenders, net interest income grew +9.1% and net profit +11.1%.

55% of companies grew net profit; 472 turned a loss into a profit; 38% beat their own profit trend and 48% fell short of it.

Updated 16 Oct 2026, 10:46 IST 5116 declared
The next results season has started: 111 companies have filed results for the quarter ended 30 Sep 2026. See them →

Q4 FY26 scoreboard

Sales growth
+12.4%
YoY, 4645 companies combined; median +11.7%
Net profit growth
+34.1%
YoY combined; median +16.1%
Operating margin
14.3%
+10 bps YoY
Grew profit
55%
472 turnarounds, 495 into loss
Vs own profit trend
38% / 48%
above / below, 14% in line
Banks: NII growth
+9.1%
120 lenders; profit +11.1%
Price since results
-6.2%
median; 28% of 36 stocks up
Other-income heavy
1375
25%+ of pre-tax profit from other income & one-offs

Latest Q4 FY26 results 5116

Page 118 of 171

Asian Petroproducts & Exports Ltd

524434 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 132 bps YoY
  • All of pre-tax profit came from other income or one-off items
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -68.2%+10.2% 10.09.131.5
Operating profit loss narrowedto loss -0.00.1-0.5
OPM % +132 bps-97 bps -0.2%0.8%-1.5%
Other income +133.3%+750.0% 1.20.10.5
Net profit from loss+940.0% 1.00.1-0.0
PAT margin % +1045 bps+929 bps 10.4%1.1%-0.1%
EPS (₹) from loss+950.0% 0.420.04-0.01

Quality of profit

Pre-tax profit ₹1.1 Cr: core business −₹0.1 Cr, other income ₹1.2 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY26 cash from operations −₹1.4 Cr: -116% of FY26 net profit of ₹1.2 Cr.

Borrowings ₹1.4 Cr at Mar 2026.

Camex Ltd

524440 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +999% above its own trend
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +11.1%+12.9% 41.436.637.2
Operating profit +20.4%+74.6% 2.51.42.1
OPM % +46 bps+212 bps 6.0%3.9%5.5%
Other income from loss+428.6% 0.40.1-1.0
Net profit —+120.7% 1.80.80.1
PAT margin % +397 bps+214 bps 4.4%2.2%0.4%
EPS (₹) —+121.2% 1.770.800.15

Quality of profit

Core 85%Other income & one-offs 15%

Pre-tax profit ₹2.5 Cr: core business ₹2.1 Cr, other income ₹0.4 Cr.

Core profit YoY: +41.5%

Cash & debt

FY26 cash from operations −₹3.0 Cr: -92% of FY26 net profit of ₹3.2 Cr.

Borrowings ₹8.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹39.0₹41.4 +5.9% above
Net profit₹0.1₹1.8 +999.0% above

Evexia Lifecare Ltd

524444 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Profit +79% above its own trend
  • Operating margin contracted 260 bps YoY
  • Operating cash flow was negative in FY26 despite a profit
  • Borrowings up 217% since Mar 2025
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +55.8%+45.8% 36.825.223.6
Operating profit -16.7%+340.0% 1.10.21.3
OPM % -260 bps+200 bps 3.0%1.0%5.6%
Other income —-61.5% 0.10.30.0
Net profit? +151.6%+169.0% 0.80.30.3
PAT margin % +81 bps+97 bps 2.1%1.1%1.3%
EPS (₹) —— 0.000.000.00

Quality of profit

Core 89%Other income & one-offs 11%

Pre-tax profit ₹0.9 Cr: core business ₹0.8 Cr, other income ₹0.1 Cr.

Core profit YoY: +77.8% · reported profit +151.6%

Cash & debt

FY26 cash from operations −₹23.0 Cr: -1111% of FY26 net profit of ₹2.1 Cr.

Borrowings ₹1,222 Cr at Sep 2025, against ₹386 Cr at Mar 2025 (+217%).

Against its own trend ?

TrendActualGap
Sales₹23.7₹36.8 +55.5% above
Net profit₹0.4₹0.8 +79.1% above

Indo Euro Indchem Ltd

524458 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 915 bps YoY
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +112.6%+544.4% 8.11.33.8
Operating profit from lossfrom loss 0.0-0.1-0.3
OPM % +915 bps+739 bps 0.2%-7.1%-8.9%
Other income -20.0%+9.1% 0.10.10.1
Net profit from loss+500.0% 0.10.0-0.1
PAT margin % +283 bps-5 bps 0.7%0.8%-2.1%
EPS (₹) from loss+600.0% 0.070.01-0.09

Quality of profit

Pre-tax profit ₹0.1 Cr: core business −₹0.0 Cr, other income ₹0.1 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY26 cash from operations ₹9.1 Cr: 2926% of FY26 net profit of ₹0.3 Cr.

Borrowings nil at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1.9₹8.1 +325.1% above

Riddhi Siddhi Gluco Biols Ltd

524480 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Profit -999% below its own trend
  • Operating margin contracted 7817 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -67.9%-77.5% 9.040.028.0
Operating profit loss widenedloss widened -8.0-6.0-3.0
OPM % -7817 bps-7389 bps -88.9%-15.0%-10.7%
Other income to lossto loss -17.013.028.0
Net profit? to lossloss widened -33.0-1.05.0
EPS (₹) to lossloss widened -45.64-2.235.09

Quality of profit

Pre-tax profit −₹31.0 Cr: core business −₹14.0 Cr, other income −₹17.0 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations −₹9.0 Cr.

Borrowings ₹283 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹21.9₹9.0 -58.8% below
Net profit₹2.5−₹33.0 -999.0% below

SVC INDUSTRIES Ltd

524488 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -36.4%-63.2% 0.10.20.1
Operating profit loss narrowedloss widened -0.3-0.1-0.5
Other income —-100.0% 0.00.00.0
Net profit loss narrowedloss widened -0.8-0.6-0.9
EPS (₹) loss narrowedloss widened -0.05-0.03-0.06

Quality of profit

Pre-tax profit −₹0.8 Cr: core business −₹0.8 Cr, other income ₹0.0 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY26 cash from operations ₹0.1 Cr.

Borrowings ₹175 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹0.2₹0.1 -68.2% below

Raaj Medisafe India Ltd

524502 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Profit -151% below its own trend
  • Operating margin contracted 194 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +2.8%+21.1% 25.120.724.4
Operating profit -12.9%-26.6% 2.73.73.1
OPM % -194 bps-701 bps 10.8%17.8%12.7%
Other income +154.5%+600.0% 0.30.00.1
Net profit to lossto loss -3.21.93.5
PAT margin % -2714 bps-2200 bps -12.9%9.1%14.3%
EPS (₹) to lossto loss -1.971.442.63

Quality of profit

Core 78%Other income & one-offs 22%

Pre-tax profit ₹1.3 Cr: core business ₹1.0 Cr, other income ₹0.3 Cr.

Core profit YoY: -49.7%

Cash & debt

FY26 cash from operations ₹3.7 Cr: 198% of FY26 net profit of ₹1.8 Cr.

Borrowings ₹64.2 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹38.3₹25.1 -34.5% below
Net profit₹6.3−₹3.2 -151.3% below

Coral Laboratories Ltd

524506 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +269% above its own trend
  • Operating margin expanded 1385 bps YoY
  • 32% of pre-tax profit came from other income and one-off items
  • Core business grew faster than reported profit (core profit +164%)
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -5.9%+22.8% 26.521.628.1
Operating profit +130.5%+228.0% 6.21.92.7
OPM % +1385 bps+1465 bps 23.4%8.8%9.6%
Other income +54.4%+6.0% 2.62.51.7
Net profit +84.5%+87.8% 5.22.82.8
PAT margin % +965 bps+682 bps 19.7%12.9%10.1%
EPS (₹) +84.5%+87.8% 14.617.787.92

Quality of profit

Core 68%Other income & one-offs 32%

Pre-tax profit ₹8.3 Cr: core business ₹5.7 Cr, other income ₹2.6 Cr.

Core profit YoY: +164.0% · reported profit +84.5%

Cash & debt

FY26 cash from operations ₹16.0 Cr: 98% of FY26 net profit of ₹16.4 Cr.

Borrowings ₹4.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹21.6₹26.5 +22.9% above
Net profit₹1.4₹5.2 +268.9% above

Tulasee Bio Ethanol Ltd

524514 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit —— -0.0-0.0-0.0
Other income —— 0.00.00.0
Net profit —— -0.0-0.0-0.0
EPS (₹) —— -0.07-0.07-0.07

Quality of profit

Pre-tax profit −₹0.0 Cr: core business −₹0.0 Cr, other income ₹0.0 Cr.

Cash & debt

FY26 cash from operations ₹0.0 Cr.

Borrowings nil at Mar 2026.

Bacil Pharma Ltd

524516 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit —loss widened -0.1-0.0-0.1
Other income +22.2%+83.3% 0.10.10.1
Net profit —— 0.60.00.0
EPS (₹) —— 0.430.030.01

Quality of profit

Pre-tax profit ₹0.0 Cr: core business −₹0.1 Cr, other income ₹0.1 Cr.

Cash & debt

FY26 cash from operations ₹0.7 Cr: 53% of FY26 net profit of ₹1.3 Cr.

Borrowings nil at Mar 2026.

KMC Speciality Hospitals (India) Ltd

524520 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +95% above its own trend
  • Operating margin expanded 712 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +34.4%+0.0% 82.082.061.0
Operating profit +73.3%+4.0% 26.025.015.0
OPM % +712 bps+122 bps 31.7%30.5%24.6%
Other income +100.0%+100.0% 2.01.01.0
Net profit +200.0%+7.1% 15.014.05.0
PAT margin % +1010 bps+122 bps 18.3%17.1%8.2%
EPS (₹) +221.4%+7.1% 0.900.840.28

Quality of profit

Core 90%Other income & one-offs 10%

Pre-tax profit ₹20.0 Cr: core business ₹18.0 Cr, other income ₹2.0 Cr.

Core profit YoY: +125.0% · reported profit +200.0%

Cash & debt

FY26 cash from operations ₹79.0 Cr: 165% of FY26 net profit of ₹48.0 Cr.

Borrowings ₹84.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹81.8₹82.0 +0.2% in line
Net profit₹7.7₹15.0 +94.6% above

Laffans Petrochemicals Ltd

524522 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating margin contracted 1470 bps YoY
  • FY26 operating cash flow was only 24% of profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +46.5%+96.9% 1.91.01.3
Operating profit loss widenedloss widened -0.8-0.5-0.4
OPM % -1470 bps+557 bps -43.4%-49.0%-28.7%
Other income loss widenedto loss -2.72.3-1.9
Net profit loss widenedto loss -3.31.6-2.4
EPS (₹) loss widenedto loss -4.081.95-3.05

Quality of profit

Pre-tax profit −₹3.7 Cr: core business −₹1.0 Cr, other income −₹2.7 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations ₹0.1 Cr: 24% of FY26 net profit of ₹0.4 Cr.

Borrowings ₹0.4 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹0.7₹1.9 +175.4% above

Bhaskar Agrochemicals Ltd

524534 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Profit -194% below its own trend
  • Operating margin contracted 907 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +28.1%-3.7% 28.629.722.3
Operating profit to lossto loss -0.34.31.8
OPM % -907 bps-1526 bps -0.9%14.3%8.2%
Other income +383.3%from loss 0.3-0.40.1
Net profit to lossto loss -0.82.30.7
PAT margin % -619 bps-1075 bps -2.9%7.9%3.3%
EPS (₹) to lossto loss -1.574.491.42

Quality of profit

Pre-tax profit −₹0.8 Cr: core business −₹1.1 Cr, other income ₹0.3 Cr.

Core profit YoY: to loss

Cash & debt

FY26 cash from operations ₹11.0 Cr: 240% of FY26 net profit of ₹4.6 Cr.

Borrowings ₹26.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹36.2₹28.6 -21.0% below
Net profit₹0.9−₹0.8 -194.0% below

Sharma East India Hospitals & Medical Research Ltd

524548 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +24.9%-22.3% 7.59.66.0
Operating profit +24.7%+32.9% 1.00.80.8
OPM % -2 bps+561 bps 13.5%7.9%13.5%
Other income -91.3%-60.0% 0.00.10.2
Net profit +16.2%+138.9% 0.40.20.4
PAT margin % -43 bps+388 bps 5.8%1.9%6.2%

Quality of profit

Core 95%Other income & one-offs 5%

Pre-tax profit ₹0.4 Cr: core business ₹0.4 Cr, other income ₹0.0 Cr.

Core profit YoY: — · reported profit +16.2%

Cash & debt

FY26 cash from operations −₹3.9 Cr: -309% of FY26 net profit of ₹1.2 Cr.

Borrowings ₹7.3 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹7.7₹7.5 -3.5% in line
Net profit₹0.4₹0.4 +4.6% in line

Gayatri BioOrganics Ltd

524564 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit loss widenedloss widened -0.3-0.1-0.1
Other income —— 0.00.00.0
Net profit loss widenedloss widened -0.4-0.2-0.2
EPS (₹) loss widenedloss widened -0.05-0.03-0.02

Quality of profit

Pre-tax profit −₹0.4 Cr: core business −₹0.4 Cr, other income ₹0.0 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations −₹0.7 Cr.

Borrowings ₹37.6 Cr at Mar 2026.

Pharmaids Pharmaceuticals Ltd

524572 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Operating margin expanded 7703 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +50.5%+32.2% 7.25.44.8
Operating profit loss narrowedloss narrowed -0.3-2.5-3.9
OPM % +7703 bps+4149 bps -4.7%-46.2%-81.8%
Other income -92.3%from loss 0.0-0.30.1
Net profit? loss narrowedloss narrowed -1.1-2.6-4.8
PAT margin % —+3362 bps -15.2%-48.8%—
EPS (₹) loss narrowedloss narrowed -0.51-0.70-1.12

Quality of profit

Pre-tax profit −₹1.5 Cr: core business −₹1.5 Cr, other income ₹0.0 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY26 cash from operations −₹4.0 Cr.

Borrowings ₹23.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹6.1₹7.2 +17.6% above

Vivid Global Industries Ltd

524576 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +28% above its own trend
  • Operating margin expanded 353 bps YoY
  • 62% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +11.4%-0.9% 14.614.713.1
Operating profit +183.3%+84.8% 0.80.50.3
OPM % +353 bps+270 bps 5.8%3.1%2.3%
Other income +5.9%+5.9% 0.20.20.2
Net profit +125.0%+42.1% 0.30.20.1
PAT margin % +93 bps+56 bps 1.8%1.3%0.9%
EPS (₹) +130.8%+42.9% 0.300.210.13

Quality of profit

Core 38%Other income & one-offs 62%

Pre-tax profit ₹0.3 Cr: core business ₹0.1 Cr, other income ₹0.2 Cr.

Core profit YoY: — · reported profit +125.0%

Cash & debt

FY26 cash from operations ₹11.3 Cr: 1527% of FY26 net profit of ₹0.7 Cr.

Borrowings ₹1.8 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹21.2₹14.6 -31.2% below
Net profit₹0.2₹0.3 +27.6% above

Priya Ltd

524580 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit loss widenedloss narrowed -0.0-0.0-0.0
Other income —-100.0% 0.08.00.0
Net profit loss narrowedto loss -0.97.1-0.9
EPS (₹) loss narrowedto loss -3.0023.75-3.03

Quality of profit

Pre-tax profit −₹0.9 Cr: core business −₹0.9 Cr, other income ₹0.0 Cr.

Cash & debt

FY26 cash from operations ₹7.8 Cr: 180% of FY26 net profit of ₹4.3 Cr.

Borrowings ₹17.2 Cr at Mar 2026.

Tirupati Starch & Chemicals Ltd

524582 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Profit +217% above its own trend
  • Operating margin expanded 488 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -7.8%-2.3% 89.991.997.5
Operating profit +109.9%+31.5% 7.85.93.7
OPM % +488 bps+223 bps 8.7%6.5%3.8%
Other income -97.4%-95.3% 0.12.13.9
Net profit? +58.4%-0.8% 2.42.51.5
PAT margin % +114 bps+4 bps 2.7%2.7%1.6%
EPS (₹) +57.8%-1.2% 2.542.571.61

Quality of profit

Core 97%Other income & one-offs 3%

Pre-tax profit ₹3.5 Cr: core business ₹3.4 Cr, other income ₹0.1 Cr.

Core profit YoY: from loss · reported profit +58.4%

Cash & debt

FY26 cash from operations ₹42.0 Cr: 643% of FY26 net profit of ₹6.5 Cr.

Borrowings ₹110 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹97.3₹89.9 -7.7% below
Net profit₹0.8₹2.4 +216.9% above

Hemo Organic Ltd

524590 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Operating margin contracted 3848 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -61.4%— 0.90.02.4
Operating profit to lossloss widened -0.3-0.10.1
OPM % -3848 bps— -32.3%—6.2%
Other income -100.0%— 0.00.00.1
Net profit to lossloss widened -0.5-0.20.4
PAT margin % -7019 bps— -54.8%—15.4%
EPS (₹) to lossloss widened -1.47-0.461.07

Quality of profit

Pre-tax profit −₹0.3 Cr: core business −₹0.3 Cr, other income ₹0.0 Cr.

Core profit YoY: to loss

Cash & debt

FY26 cash from operations −₹1.5 Cr.

Borrowings ₹2.7 Cr at Mar 2026.

Jaysynth Orgochem Ltd

524592 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Profit +145% above its own trend
  • Operating margin expanded 254 bps YoY
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +16.1%+6.2% 69.565.459.8
Operating profit +48.9%+104.9% 8.03.95.4
OPM % +254 bps+555 bps 11.5%6.0%9.0%
Other income +114.9%+90.6% 1.00.50.5
Net profit? +85.0%+142.9% 5.72.33.1
PAT margin % +303 bps+459 bps 8.1%3.6%5.1%
EPS (₹) +82.6%+147.1% 0.420.170.23

Quality of profit

Core 87%Other income & one-offs 13%

Pre-tax profit ₹8.0 Cr: core business ₹7.0 Cr, other income ₹1.0 Cr.

Core profit YoY: +67.1% · reported profit +85.0%

Cash & debt

FY26 cash from operations −₹7.0 Cr: -48% of FY26 net profit of ₹14.7 Cr.

Borrowings ₹42.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹66.7₹69.5 +4.2% in line
Net profit₹2.3₹5.7 +145.1% above

Aeonx Digital Technology Ltd

524594 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Profit -219% below its own trend
  • Operating margin contracted 1737 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +72.9%+4.0% 16.515.99.6
Operating profit to lossloss widened -1.9-0.60.6
OPM % -1737 bps-759 bps -11.6%-4.0%5.8%
Other income -9.3%+302.9% 1.40.31.5
Net profit? to lossloss widened -0.8-0.71.3
PAT margin % -1869 bps-56 bps -4.8%-4.2%13.9%
EPS (₹) to lossloss widened -1.72-1.462.89

Quality of profit

Pre-tax profit −₹1.1 Cr: core business −₹2.4 Cr, other income ₹1.4 Cr.

Core profit YoY: to loss

Cash & debt

FY26 cash from operations −₹2.9 Cr.

Borrowings ₹1.4 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹13.9₹16.5 +19.0% above
Net profit₹0.7−₹0.8 -218.8% below

Bandaram Pharma Packtech Ltd

524602 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Profit +20% above its own trend
  • Operating margin contracted 324 bps YoY
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +209.3%+77.0% 26.314.88.5
Operating profit +51.9%-18.0% 0.81.00.5
OPM % -324 bps-362 bps 3.1%6.7%6.4%
Other income -88.9%— 0.00.00.1
Net profit? -40.0%-74.3% 0.10.30.1
PAT margin % -142 bps-202 bps 0.3%2.4%1.8%
EPS (₹) -58.3%-54.5% 0.050.110.12

Quality of profit

Core 92%Other income & one-offs 8%

Pre-tax profit ₹0.1 Cr: core business ₹0.1 Cr, other income ₹0.0 Cr.

Core profit YoY: -0.0% · reported profit -40.0%

Cash & debt

FY26 cash from operations −₹4.9 Cr: -946% of FY26 net profit of ₹0.5 Cr.

Borrowings ₹23.9 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹9.3₹26.3 +181.6% above
Net profit₹0.1₹0.1 +20.0% above

Adline Chem Lab Ltd

524604 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit loss widenedloss widened -0.1-0.0-0.1
Other income -96.0%— 0.00.00.2
Net profit to lossloss widened -0.1-0.10.2
EPS (₹) to lossloss widened -0.15-0.100.36

Quality of profit

Pre-tax profit −₹0.1 Cr: core business −₹0.1 Cr, other income ₹0.0 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations −₹0.2 Cr.

Borrowings ₹1.8 Cr at Mar 2026.

Beryl Drugs Ltd

524606 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +608% above its own trend
  • Operating margin expanded 1492 bps YoY
  • Core business grew faster than reported profit (core profit +770%)
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +4.8%+42.1% 5.53.95.2
Operating profit +168.0%from loss 1.3-0.20.5
OPM % +1492 bps+2969 bps 24.5%-5.2%9.6%
Other income —— 0.00.00.0
Net profit +273.3%from loss 0.6-0.20.1
PAT margin % +736 bps+1465 bps 10.2%-4.4%2.9%
EPS (₹) +266.7%from loss 1.10-0.340.30

Quality of profit

Core 100%Other income & one-offs 0%

Pre-tax profit ₹0.9 Cr: core business ₹0.9 Cr, other income ₹0.0 Cr.

Core profit YoY: +770.0% · reported profit +273.3%

Cash & debt

FY26 cash from operations ₹3.6 Cr: 869% of FY26 net profit of ₹0.4 Cr.

Borrowings ₹2.4 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹4.4₹5.5 +24.5% above
Net profit₹0.1₹0.6 +608.4% above

IEL Ltd

524614 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • 49% of pre-tax profit came from other income and one-off items
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —-23.6% 0.40.60.0
Operating profit from loss-8.9% 0.40.5-0.3
OPM % —+1580 bps 97.6%81.8%—
Other income —+966.7% 0.30.00.0
Net profit from loss+25.5% 0.60.5-0.2
EPS (₹) from loss+25.0% 0.050.04-0.02

Quality of profit

Core 51%Other income & one-offs 49%

Pre-tax profit ₹0.7 Cr: core business ₹0.3 Cr, other income ₹0.3 Cr.

Core profit YoY: from loss

Cash & debt

FY26 cash from operations −₹0.0 Cr: -22% of FY26 net profit of ₹0.2 Cr.

Borrowings ₹0.9 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹0.0₹0.4 +999.0% above

iStreet Network Ltd

524622 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating margin contracted 368 bps YoY
  • Core business grew faster than reported profit (core profit +85%)
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +586.9%+68.2% 41.524.76.0
Operating profit +124.2%-48.3% 0.71.40.3
OPM % -368 bps-402 bps 1.8%5.8%5.5%
Other income +100.0%— 0.00.00.0
Net profit +11.4%-67.5% 0.41.20.3
PAT margin % -485 bps-393 bps 0.9%4.9%5.8%
EPS (₹) -62.5%-66.7% 0.060.180.16

Quality of profit

Core 94%Other income & one-offs 6%

Pre-tax profit ₹0.7 Cr: core business ₹0.6 Cr, other income ₹0.0 Cr.

Core profit YoY: +84.8% · reported profit +11.4%

Cash & debt

FY26 cash from operations −₹35.2 Cr: -710% of FY26 net profit of ₹5.0 Cr.

Borrowings ₹0.3 Cr at Mar 2026.

Gagan Gases Ltd

524624 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -41% below its own trend
  • Operating margin contracted 259 bps YoY
  • 33% of pre-tax profit came from other income and one-off items
  • Core business grew faster than reported profit (core profit +71%)
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +72.4%+5.8% 1.81.71.1
Operating profit +33.3%+60.0% 0.20.10.1
OPM % -259 bps+299 bps 8.8%5.8%11.4%
Other income -45.5%— 0.10.00.1
Net profit +18.2%+62.5% 0.10.10.1
PAT margin % -329 bps+250 bps 7.2%4.7%10.5%
EPS (₹) +20.8%+61.1% 0.290.180.24

Quality of profit

Core 67%Other income & one-offs 33%

Pre-tax profit ₹0.2 Cr: core business ₹0.1 Cr, other income ₹0.1 Cr.

Core profit YoY: +71.4% · reported profit +18.2%

Cash & debt

FY26 cash from operations −₹0.1 Cr: -100% of FY26 net profit of ₹0.1 Cr.

Borrowings ₹0.4 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1.1₹1.8 +66.3% above
Net profit₹0.2₹0.1 -40.9% below

Parker Agrochem Exports Ltd

524628 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +11% above its own trend
  • Operating margin expanded 2633 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -88.0%-6.8% 1.41.511.4
Operating profit +14.3%+14.3% 0.40.30.3
OPM % +2633 bps+544 bps 29.4%24.0%3.1%
Other income +200.0%+200.0% 0.00.00.0
Net profit +120.0%+200.0% 0.30.10.1
PAT margin % +2294 bps+1673 bps 24.3%7.5%1.3%
EPS (₹) +122.6%+200.0% 0.690.230.31

Quality of profit

Core 92%Other income & one-offs 8%

Pre-tax profit ₹0.4 Cr: core business ₹0.3 Cr, other income ₹0.0 Cr.

Core profit YoY: +25.9% · reported profit +120.0%

Cash & debt

FY26 cash from operations ₹0.8 Cr: 90% of FY26 net profit of ₹0.9 Cr.

Borrowings ₹0.3 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹22.7₹1.4 -94.0% below
Net profit₹0.3₹0.3 +10.8% above

Shukra Pharmaceuticals Ltd

524632 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Operating margin contracted 4401 bps YoY
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -52.4%-83.8% 6.339.113.3
Operating profit -90.4%-97.4% 0.727.17.3
OPM % -4401 bps-5826 bps 11.1%69.3%55.1%
Other income -35.4%+15.9% 0.90.81.5
Net profit? to lossto loss -1.720.45.4
PAT margin % -6783 bps-7925 bps -27.2%52.0%40.6%
EPS (₹) to lossto loss -0.040.460.12

Quality of profit

Pre-tax profit ₹0.4 Cr: core business −₹0.6 Cr, other income ₹0.9 Cr.

Core profit YoY: to loss

Cash & debt

FY26 cash from operations ₹4.0 Cr.

Borrowings ₹5.0 Cr at Mar 2026.

How to read this page

The numbers. Each card is one company's Q4 FY26 results as filed with NSE or BSE, read from the filing within hours of its release, in ₹ crore. We show the consolidated statement, or the standalone one when the consolidated figures are a copy of it or have no year-ago quarter to compare with. YoY compares with the same quarter a year earlier and QoQ with the quarter before (the previous half-year for companies that report every six months). A swing between profit and loss is described in words: a percentage across it would mislead.

Net profit. On a consolidated statement, net profit is the profit of the whole group for the quarter, before minority interest. A company's own headline, and the AI read of its filing, often quote the profit attributable to its shareholders instead, which is lower when subsidiaries are partly owned: Larsen & Toubro's Q1 FY27 group profit was ₹4,988 Cr, of which ₹4,123 Cr belonged to its shareholders. EPS is worked out on that attributable profit, so EPS and net profit need not grow at the same rate. On a standalone statement the two are the same.

Margins. Operating margin (OPM) is operating profit, before depreciation, interest and other income, as a share of sales; PAT margin is net profit as a share of sales. Their changes are in basis points (100 bps = 1 percentage point).

Quality of profit. Core profit is operating profit minus interest and depreciation: what the business itself earned before tax. The rest of pre-tax profit is other income (interest on cash, dividends, gains on investments) and exceptional or one-off items. We flag a quarter when that share is 25% or more, and when reported profit grew much faster than core profit. For banks we compare pre-provision profit with net profit, since a fall in provisions can lift profit without the business growing.

Against its own trend. We do not have analyst consensus estimates, and we do not make them up. Instead each company is measured against the path it was on: the same quarter last year, grown at the median of its last four year-on-year growth rates (held between −50% and +100%; at least two growth rates needed). Sales 5% or more above that, or net profit 10% or more above, is "above trend"; as far below is "below trend". It answers "was this quarter better or worse than the company's own recent run?", which consensus does not.

Cash and debt. Profit is an accounting figure; cash is harder to dress up. For each company we show its operating cash flow for the last financial year as a share of that year's net profit (flagged under 50%, or when it is negative despite a profit), and its borrowings at the latest balance sheet against the one six months earlier (flagged at a 25% move). Balance sheets come with the September and March results, the year's cash-flow statement with the March results and the half-year's (April to September) with the September results.

Management guidance. When a company files the transcript of its earnings call, we read what its management said to expect: revenue or profit growth, margins, capex and the like, for this financial year or part of it. A figure is kept only when the sentence that states it is found in the transcript, and you can read it under "What management said". Growth and margins are then set beside the actual so far: the year-to-date quarters against the same quarters a year earlier (so the first half is measured against a full-year figure). Within 1 percentage point of the range for growth, or 0.5 for margins, is "on track"; above it "ahead", below it "behind". A new figure for the same period is marked raised or cut against the one before. This is what management said, not a forecast of ours.

Working capital. Inventory, trade receivables and trade payables from the same balance sheets, each also as days of sales (the amount against the twelve months' sales to that date, times 365). Receivables or inventory that grow 25 points or more faster than sales between two balance sheets (and by at least 20%) are flagged: money tied up in customers and stock is profit not yet in cash. These lines are read from filings since the September 2026 results, so comparisons with an earlier balance sheet start with the March 2027 results for most companies.

Price since results. The latest close against the last close before the filing (a filing after 3:30 pm counts from the next session). It is a fact about the market's reaction, not advice.

Market cap groups. Large cap is the 100 largest companies by market value and mid cap the next 150 (SEBI's ranking); below that, small cap is ₹5,000 Cr or more, micro cap ₹500 Cr or more, nano cap below.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI